Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
Clinical trial NCT05470582 · COMPLETED
Trial details
- NCT number
- NCT05470582
- Sponsor
- St. Petersburg Research Institute of Vaccines and Sera
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2021-10-29
- Enrollment
- 1066
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.